Stockreport

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF reached 64.1 million shares, coming in about 3,077% above its three-month average of 2 million shares. Tuesday's move followed Phase 3 psoriasis data for envudeucitini [Read more]